Kitov Pharma Ltd. Warrants
KTOVW
KTOVW was delisted on the 23rd of November, 2020.
4 hedge funds and large institutions have $8K invested in Kitov Pharma Ltd. Warrants in 2020 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 1 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
69% less capital invested
Capital invested by funds: $26K → $8K (-$18K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$1.21K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$6K |
| 2 |
VF
Virtu Financial
New York
|
-$1.78K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$693 |
KTOVW Hedge Fund Activity: Q3 2020 in Review
4 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Kitov Pharma Ltd. Warrants (KTOVW) for Q3 2020, worth a combined $8K — down 69% from $26K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of KTOVW and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 1 added.
The largest buyer was HRT Financial, adding an estimated $1.21K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $6K sold.
- 4 institutional investors held Kitov Pharma Ltd. Warrants (KTOVW) as of Q3 2020, down from 5 in Q2 2020.
- Funds reported $8K of Kitov Pharma Ltd. Warrants stock for Q3 2020, down 69% quarter-over-quarter.
- 0 funds opened new Kitov Pharma Ltd. Warrants positions in Q3 2020 and 1 closed out, a net change of -1 holder.
- The largest Kitov Pharma Ltd. Warrants buyer in Q3 2020 was HRT Financial, an estimated $1.21K added.
- The largest Kitov Pharma Ltd. Warrants seller in Q3 2020 was Susquehanna International Group, an estimated $6K sold.
Based on aggregated 13F filings for Q3 2020.